Bextra

Bextra is another COX-2 inhibitor (like Vioxx and Celebrex) that was available for years before its side effects were widely publicized. Bextra was approved by the FDA in November 2001 to alleviate osteoarthritis, rheumatoid arthritis, and severe menstrual pain. Like other COX-2 drugs, Bextra would not cause the same gastrointestinal problems as other painkillers. However, similar to the other COX-2 drugs, Vioxx and Celebrex, Bextra studies demonstrated that the drug increased the likelihood of heart attack and stroke among users.

Bextra has also been shown to cause the rare but potentially deadly skin disease Stevens-Johnson Syndrome. Stevens-Johnson Syndrome can affect the mucous membranes of the oral cavity, nostril, eyes, and both the anal and genital regions.

Despite the Vioxx recall, Bextra remained available for sale until April 7, 2005, at which point the FDA asked Pfizer to remove Bextra from the market. Nationwide, lawyers are preparing lawsuits on behalf of patients who were injured after taking Bextra.

If you or a loved one has been harmed by Bextra or another dangerous drug, please call or email our experienced Bextra side effects lawyers today. We'll evaluate your claim for free and help you get the justice you deserve.